The Data Gap in Indian Medicine
Unlocking India's patient data to close critical gaps in global drug development
India's 1.4 billion people remain largely absent from the clinical trials and pipelines that define modern medicine. The data exists, scattered across hospital systems and siloed from global science. Zyren Bio connects Indian hospitals, patients, and the global research community to change this.
1.4B
people, one of the world's most genetically diverse patient populations
<2%
of global clinical trials have any study sites in India
4,600+
distinct genetic subgroups absent from global drug development
Our Goals
-
Unlock India's patient data to power globally relevant research grounded in real-world Indian evidence
-
Build a truly inclusive drug development ecosystem reflecting India's genetic, clinical, and demographic reality
-
Connect Indian patients to next-generation therapies, directly improving quality of life and standards of care
The Opportunity
-
Strengthen your research profile and visibility within global clinical and academic networks
-
Enable clinicians to participate in international studies and trials anchored in Indian patient data
-
Generate institutional value from the patient data your hospital already holds